SOFVASC HCT 5/160/12.5MG TAB

SOFVASC HCT is a triple-combination antihypertensive tablet containing Amlodipine 5mg, Valsartan 160mg, and Hydrochlorothiazide 12.5mg. This formulation is designed to manage high blood pressure effectively by combining three different mechanisms of action. Amlodipine works as a calcium channel blocker to relax blood vessels, Valsartan is an angiotensin II receptor blocker that reduces vasoconstriction, and Hydrochlorothiazide is a thiazide diuretic that helps reduce fluid volume. Together, these components provide comprehensive blood pressure control for patients requiring multi-drug therapy. SOFVASC HCT is indicated for patients whose blood pressure is not adequately controlled with dual therapy or those who require simplified dosing with a single tablet. Each tablet contains the precise combination needed for optimal therapeutic effect. Store at room temperature away from moisture and heat. Keep out of reach of children. Use only as directed by your healthcare provider.